Bio-Techne Corporation (TECH)
NASDAQ: TECH · Real-Time Price · USD
58.27
+1.17 (2.05%)
At close: Dec 19, 2025, 4:00 PM EST
58.33
+0.06 (0.10%)
After-hours: Dec 19, 2025, 7:38 PM EST
Bio-Techne Revenue
Bio-Techne had revenue of $286.56M in the quarter ending September 30, 2025, a decrease of -1.00%. This brings the company's revenue in the last twelve months to $1.22B, up 3.85% year-over-year. In the fiscal year ending June 30, 2025, Bio-Techne had annual revenue of $1.22B with 5.23% growth.
Revenue (ttm)
$1.22B
Revenue Growth
+3.85%
P/S Ratio
7.51
Revenue / Employee
$392,494
Employees
3,100
Market Cap
9.08B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Jun 30, 2025 | 1.22B | 60.58M | 5.23% |
| Jun 30, 2024 | 1.16B | 22.36M | 1.97% |
| Jun 30, 2023 | 1.14B | 31.10M | 2.81% |
| Jun 30, 2022 | 1.11B | 174.57M | 18.75% |
| Jun 30, 2021 | 931.03M | 192.34M | 26.04% |
| Jun 30, 2020 | 738.69M | 24.69M | 3.46% |
| Jun 30, 2019 | 714.01M | 71.01M | 11.04% |
| Jun 30, 2018 | 642.99M | 79.99M | 14.21% |
| Jun 30, 2017 | 563.00M | 63.98M | 12.82% |
| Jun 30, 2016 | 499.02M | 46.78M | 10.34% |
| Jun 30, 2015 | 452.25M | 94.48M | 26.41% |
| Jun 30, 2014 | 357.76M | 47.19M | 15.19% |
| Jun 30, 2013 | 310.58M | -3.99M | -1.27% |
| Jun 30, 2012 | 314.56M | 24.60M | 8.48% |
| Jun 30, 2011 | 289.96M | 20.92M | 7.77% |
| Jun 30, 2010 | 269.05M | 5.09M | 1.93% |
| Jun 30, 2009 | 263.96M | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| UnitedHealth Group | 435.16B |
| Johnson & Johnson | 92.15B |
| Merck & Co. | 64.24B |
| AbbVie | 59.64B |
| Eli Lilly and Company | 59.42B |
| AstraZeneca | 58.13B |
| Novartis AG | 56.37B |
| Novo Nordisk | 49.58B |
TECH News
- 10 days ago - Bio-Techne Launches the Enhanced Leo™ System Delivering Advanced Multiplexing and High-Throughput Protein Analysis - PRNewsWire
- 10 days ago - Bio-Techne Corporation (TECH) Presents at 53rd Annual Nasdaq Investor Conference Transcript - Seeking Alpha
- 16 days ago - Bio-Techne Corporation (TECH) Presents at Citi Annual Global Healthcare Conference 2025 Transcript - Seeking Alpha
- 17 days ago - Bio-Techne Corporation (TECH) Presents at Evercore 8th Annual Healthcare Conference Transcript - Seeking Alpha
- 24 days ago - Bio-Techne to Present at Upcoming Investor Conferences - PRNewsWire
- 4 weeks ago - Bio-Techne Corporation (TECH) Presents at Jefferies London Healthcare Conference 2025 Transcript - Seeking Alpha
- 4 weeks ago - Bio-Techne Corporation (TECH) Presents at Stephens Annual Investment Conference 2025 Transcript - Seeking Alpha
- 4 weeks ago - Bio-Techne Licenses AI-Designed NovoBody™ Duo Molecules from Monod Bio to Expand Recombinant Protein Portfolio - PRNewsWire